Market Tracker

05/21 11:06am ET

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

58.63
Data as of 10:50am ET
 +0.14 / +0.24%
Today’s Change
40.38
Today|||52-Week Range
60.79
+10.10%
Year-to-Date

Today’s Trading

Previous close58.49
Today’s open58.42
Day’s range58.32 - 59.22
Volume73,836
Average volume (3 months)754,199
Market cap$3.4B
Dividend yield--
Data as of 10:50am ET, 05/21/2013

Growth & Valuation

Earnings growth (last year)+57.63%
Earnings growth (this year)+27.52%
Earnings growth (next 5 years)+20.50%
Revenue growth (last year)+115.21%
P/E ratio23.5
Price/Sales5.15
Price/Book3.03

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...-0.31-0.46%
MDVNMedivation Inc+0.11+0.22%
SLXPSalix Pharmaceutical...+0.29+0.49%
THRXTheravance Inc+0.33+0.89%
Data as of 11:06am ET, 05/21/2013

Financials

Next reporting dateAugust 13, 2013
EPS forecast (this quarter)$1.52
Annual revenue (last year)$586.0M
Annual profit (last year)$253.3M
Net profit margin44.57%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Bruce C. Cozadd, MBA
Secretary &
Executive VP-Technical Operations
Fintan Keegan
Corporate headquarters
Dublin, Dublin

Forecasts